| Joseph Werner, CRNA | |
|
240 Minnesota St, Rapid City, SD 57701-6200 | |
| (605) 381-2550 | |
| (605) 348-6146 |
| Full Name | Joseph Werner |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 240 Minnesota St, Rapid City, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649265018 | NPI | - | NPPES |
| 5751003 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | CR000379 (South Dakota) | Primary |
| Entity Name | Avera St Marys |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669457180 PECOS PAC ID: 0143134965 Enrollment ID: O20040225000579 |
News Archive
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
Using the Vienna classification system, it has been shown in clinic-based cohorts that there can be a significant change in disease behavior over time, whereas disease location remains relatively stable. Clinical and environmental factors as well as medical therapy might be relevant in predicting disease behavior change in patients with CD.
Bird flu is in the news again following the revelation that a dead crow found recently at a local community in Hong Kong was confirmed to be H5N1 positive.
The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.
› Verified 8 days ago
| Entity Name | Black Hills Regional Eye Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174654081 PECOS PAC ID: 7113909201 Enrollment ID: O20040602001563 |
News Archive
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
Using the Vienna classification system, it has been shown in clinic-based cohorts that there can be a significant change in disease behavior over time, whereas disease location remains relatively stable. Clinical and environmental factors as well as medical therapy might be relevant in predicting disease behavior change in patients with CD.
Bird flu is in the news again following the revelation that a dead crow found recently at a local community in Hong Kong was confirmed to be H5N1 positive.
The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.
› Verified 8 days ago
| Entity Name | Black Hills Surgical Hospital Llp |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1376896621 PECOS PAC ID: 5496742835 Enrollment ID: O20130513000380 |
News Archive
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
Using the Vienna classification system, it has been shown in clinic-based cohorts that there can be a significant change in disease behavior over time, whereas disease location remains relatively stable. Clinical and environmental factors as well as medical therapy might be relevant in predicting disease behavior change in patients with CD.
Bird flu is in the news again following the revelation that a dead crow found recently at a local community in Hong Kong was confirmed to be H5N1 positive.
The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.
› Verified 8 days ago
| Entity Name | Peloton Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912596545 PECOS PAC ID: 7911312178 Enrollment ID: O20210219002480 |
News Archive
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
Using the Vienna classification system, it has been shown in clinic-based cohorts that there can be a significant change in disease behavior over time, whereas disease location remains relatively stable. Clinical and environmental factors as well as medical therapy might be relevant in predicting disease behavior change in patients with CD.
Bird flu is in the news again following the revelation that a dead crow found recently at a local community in Hong Kong was confirmed to be H5N1 positive.
The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Werner, CRNA 240 Minnesota St, Rapid City, SD 57701-6200 Ph: (605) 381-2550 | Joseph Werner, CRNA 240 Minnesota St, Rapid City, SD 57701-6200 Ph: (605) 381-2550 |
News Archive
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
Using the Vienna classification system, it has been shown in clinic-based cohorts that there can be a significant change in disease behavior over time, whereas disease location remains relatively stable. Clinical and environmental factors as well as medical therapy might be relevant in predicting disease behavior change in patients with CD.
Bird flu is in the news again following the revelation that a dead crow found recently at a local community in Hong Kong was confirmed to be H5N1 positive.
The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.
› Verified 8 days ago
Dawn Jo Zastoupil, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57501 Phone: 605-755-1000 | |
Patrick Staedtler, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-1000 | |
Joseph W Amo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 | |
Jessica Anne Newman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 | |
Karen A Bryant, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd., Rapid City, SD 57701 Phone: 605-719-1000 | |
Mr. Peter Schwiesow, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 216 Anamaria Dr, Rapid City, SD 57701 Phone: 606-721-4700 | |
Katie Kristine Bates, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 Fax: 605-719-7884 |